1.
Møller DS,
Nielsen TB,
Brink C,
Hoffmann L,
Lutz CM,
Drøgemüller Lund M,
et al.
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized,
multi-centre phase-III study.
Radiother Oncol [Internet].
2017 [cited 2018 May 16]; 124(2):311–7
2.
Even AJG,
Stoep J van der,
Zegers CML,
Reymen B,
Troost EGC,
Lambin P,
et al.
PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes.
Radiother Oncol [Internet].
2015 [cited 2018 May 16]; 116(2):281–6
3. Hoffmann L,
Knap MM,
Khalil AA,
Lutz CM,
Sloth Møller D.
The NARLAL2 dose escalation trial: dosimetric implications of inter-fractional changes in organs at risk.
Acta Oncol [Internet].
2018 [cited 2018 May 16]; 57(4):473–9
4.
Yap ML,
Sun A,
Higgins J,
Clarke K,
Marshall A,
Becker N,
et al.
Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer.
Clin Oncol [Internet].
2016 [cited 2018 May 16]; 28(12):e199– 205
5. Wanet M,
Delor A,
Hanin F-X,
Ghaye B,
Van Maanen A,
Remouchamps V,
et al.
An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.
Strahlenther Onkol [Internet].
2017 [cited 2018 May 16]; 193(10):812–22
6. Elmpt W van,
De Ruysscher D,
Salm A van der,
Lakeman A,
Stoep J van der,
Emans D,
et al.
The PET-boost randomised phase II dose-escalation trial in nonsmall cell lung cancer.
Radiother Oncol [Internet].
2012 [cited 2018 May 16]; 104(1):67–7
7.
Ding X,
Li H,
Wang Z,
Huang W,
Li B,
Zang R,
et al.
A Clinical Study of Shrinking Field Radiation Therapy Based on 18F-FDG PET/CT for Stage III Non-Small Cell Lung Cancer.
Technol Cancer Res Treat [Internet].
2013 [cited 2018 May 16]; 12(3):251–7
8.
Mac Manus MP,
Everitt S,
Bayne M,
Ball D,
Plumridge N,
Binns D,
et al.
The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: Results of a prospective study with mature survival data.
Radiother Oncol [Internet].
2013 [cited 2018 May 16]; 106(3):292–8